‘Time is prognosis’ in heart failure: time‐to‐treatment initiation as a modifiable risk factor

MLA

Marco Metra, et al. “‘Time Is Prognosis’ in Heart Failure: Time‐to‐treatment Initiation as a Modifiable Risk Factor.” ESC Heart Failure, vol. 8, no. 6, Dec. 2021, pp. 4444–53. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....18f9465bfa18cbe5f49b27bf158d2be9&authtype=sso&custid=ns315887.

APA

Marco Metra, Javed Butler, Andrew J.S. Coats, Ingrid Kindermann, Wilfried Mullens, Jan Wintrich, Stefan D. Anker, Mitja Lainscak, Jonathan Slawik, Lars H. Lund, Amr Abdin, Giuseppe M.C. Rosano, & Michael Böhm. (2021). ‘Time is prognosis’ in heart failure: time‐to‐treatment initiation as a modifiable risk factor. ESC Heart Failure, 8(6), 4444–4453.

Chicago

Marco Metra, Javed Butler, Andrew J.S. Coats, Ingrid Kindermann, Wilfried Mullens, Jan Wintrich, Stefan D. Anker, et al. 2021. “‘Time Is Prognosis’ in Heart Failure: Time‐to‐treatment Initiation as a Modifiable Risk Factor.” ESC Heart Failure 8 (6): 4444–53. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....18f9465bfa18cbe5f49b27bf158d2be9&authtype=sso&custid=ns315887.